| Temozolomide studied in …STUDIED_INderived200 of 781show all (up to 200) |
|---|
| → studied in | NCT01824875Phase 2 · completed Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · 781 trials list this drug (199 active) | — | — | Gastrin-Producing Neuroendocrine Tumor,Pancreatic Glucagonoma,Pancreatic Insulinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685004Phase 2/Phase 3 · active not recruiting Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) · 781 trials list this drug (199 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902169Phase 3 · recruiting Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432804Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype,MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326566Phase 2 · recruiting Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioma,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · 781 trials list this drug (199 active) | — | — | Medulloblastoma,Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07104032Phase 3 · recruiting IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195591Phase 3 · recruiting Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899155Phase 2 · recruiting Pan Tumor Rollover Study · 781 trials list this drug (199 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015242Phase 2 · recruiting A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma · 781 trials list this drug (199 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708961Phase 2 · suspended Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma,Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · 781 trials list this drug (199 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3,Astrocytoma, IDH-Mutant, Grade 2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765812Phase 1/Phase 2 · recruiting A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587038Phase 1 · active not recruiting OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816927Phase 2 · recruiting Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03535350Phase 1 · active not recruiting Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07492680Phase 2 · recruiting A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) · 781 trials list this drug (199 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioma,Diffuse Midline Glioma, H3 K27M-Mutant+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligodendroglioma,Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243470Phase 1/Phase 2 · recruiting Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors · 781 trials list this drug (199 active) | — | — | Adult Central Nervous System Neoplasm,Childhood Central Nervous System Neoplasm,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · 781 trials list this drug (199 active) | — | — | Medulloblastoma,Diffuse Intrinsic Pontine Glioma,Diffuse Midline Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01356290Phase 2 · recruiting Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394858Phase 2 · active not recruiting Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · 781 trials list this drug (199 active) | — | — | Paraganglioma,Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · 781 trials list this drug (199 active) | — | — | Glioblastoma,Adult Glioblastoma,Supratentorial Glioblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349693Phase 2/Phase 3 · not yet recruiting Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype,MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811297Phase 1/Phase 2 · not yet recruiting A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers · 781 trials list this drug (199 active) | — | — | Glioblastoma,Ovarian Neoplasm,Soft Tissue Sarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410248Phase 1 · recruiting Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype,WHO Grade 2 Glioma,WHO Grade 3 Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715933Phase 1 · recruiting Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma,Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807878Phase 2 · not yet recruiting Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma · 781 trials list this drug (199 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma,Liposarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · 781 trials list this drug (199 active) | — | — | Pancreatic Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215910Phase 3 · recruiting Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer · 781 trials list this drug (199 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142241Phase 2 · active not recruiting Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial · 781 trials list this drug (199 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02179086Phase 2 · active not recruiting Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma,Childhood Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789379Phase 2 · not yet recruiting Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioblastoma, IDH-Wildtype,Astrocytoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019327Phase 1/Phase 2 · terminated A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer · 781 trials list this drug (199 active) | — | — | Prostate Adenocarcinoma,Prostate Neoplasm,Malignant Prostate Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096481Phase 2 · recruiting PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma · 781 trials list this drug (199 active) | — | — | Medulloblastoma,Diffuse Intrinsic Pontine Glioma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463848Phase 2 · active not recruiting Surgical Pembro +/- Olaparib w TMZ for rGBM · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · 781 trials list this drug (199 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06202066Phase 2 · suspended Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas · 781 trials list this drug (199 active) | — | — | Digestive System Neuroendocrine Neoplasm,Malignant Solid Neoplasm,Lung Neuroendocrine Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02977780Phase 2 · recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06556563Phase 3 · recruiting EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762716Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03122197early Phase 1 · recruiting Study of Letrozole in Recurrent Gliomas · 781 trials list this drug (199 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728361Phase 2 · completed Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer · 781 trials list this drug (199 active) | — | — | Malignant Lung Neoplasm,Neuroendocrine Carcinoma,Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743126Phase 3 · recruiting SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma · 781 trials list this drug (199 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05030298Phase 1 · recruiting Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial · 781 trials list this drug (199 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095376Phase 3 · active not recruiting Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05417594Phase 1/Phase 2 · recruiting Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 781 trials list this drug (199 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758062Phase 2 · not yet recruiting Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754734Phase 2 · not yet recruiting STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioma,MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455557Phase 2 · active not recruiting SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761070Phase 3 · completed Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999994Phase 2 · recruiting A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer · 781 trials list this drug (199 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02970448early Phase 1 · completed Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas · 781 trials list this drug (199 active) | — | — | High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691491Phase 1/Phase 2 · recruiting Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness · 781 trials list this drug (199 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Malignant Solid Neoplasm,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970447Phase 2/Phase 3 · recruiting A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337177Phase 1 · active not recruiting Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors · 781 trials list this drug (199 active) | — | — | Solid Neoplasm,Hepatoblastoma,Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555577Phase 1 · active not recruiting Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05781321Phase 2 · active not recruiting Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Adult Glioblastoma,Brain Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03180502Phase 2 · active not recruiting Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligoastrocytoma,Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03556384Phase 2 · completed Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) · 781 trials list this drug (199 active) | — | — | Malignant Neoplasm,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743661Phase 2 · active not recruiting 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma · 781 trials list this drug (199 active) | — | — | Medulloblastoma,Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07732413Phase 1 · not yet recruiting Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer · 781 trials list this drug (199 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · 781 trials list this drug (199 active) | — | — | Gastric Neuroendocrine Carcinoma,Intestinal Neuroendocrine Carcinoma,Pancreatic Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931626Phase 1 · recruiting Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer · 781 trials list this drug (199 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721689Phase 1/Phase 2 · recruiting PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors · 781 trials list this drug (199 active) | — | — | Solid Neoplasm,Neuroblastoma,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900792Phase 1 · active not recruiting A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06450041Phase 2 · recruiting NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413706Phase 2 · active not recruiting A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581292Phase 2 · active not recruiting Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623931Phase 2 · recruiting Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas · 781 trials list this drug (199 active) | — | — | Anaplastic Oligoastrocytoma,Anaplastic Oligodendroglioma,Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707973Phase 2 · not yet recruiting Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma · 781 trials list this drug (199 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 781 trials list this drug (199 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027748Phase 1 · recruiting Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 781 trials list this drug (199 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06478212Phase 1/Phase 2 · active not recruiting Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448286Phase 3 · not yet recruiting PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189706early Phase 1 · active not recruiting Study of Chemoimmunotherapy for High-Risk Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025226early Phase 1 · recruiting Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388733Phase 3 · active not recruiting A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Brain Neoplasm,Adult Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805305Phase 2 · recruiting DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM) · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675070recruiting Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma Tumors · 781 trials list this drug (199 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177578Phase 2 · active not recruiting Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326464Phase 3 · completed Tofacitinib in Recurrent GBM Patients · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861244Phase 2 · recruiting Embryonal Tumor With Multilayered Rosettes · 781 trials list this drug (199 active) | — | — | Embryonal Tumor with Multilayered Rosettes | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00539591Phase 2 · active not recruiting Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma · 781 trials list this drug (199 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428045Phase 1 · recruiting STARLITE for Unresectable High-Grade Gliomas · 781 trials list this drug (199 active) | — | — | High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670026Phase 2 · recruiting Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04457284Phase 2 · completed Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer · 781 trials list this drug (199 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638546Phase 2 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer · 781 trials list this drug (199 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06023641Phase 2 · recruiting Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease · 781 trials list this drug (199 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588453Phase 1/Phase 2 · recruiting Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain · 781 trials list this drug (199 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011671Phase 1 · active not recruiting Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03514069Phase 1 · completed Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223034Phase 1 · recruiting A Study of 177Lu-PSMA-617 in People With Gliomas · 781 trials list this drug (199 active) | — | — | Glioma,Glioblastoma, IDH-Wildtype,Diffuse Astrocytoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164199Phase 3 · completed Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04796012Phase 1/Phase 2 · recruiting VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors · 781 trials list this drug (199 active) | — | — | Solid Neoplasm,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213002Phase 1/Phase 2 · recruiting Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM · 781 trials list this drug (199 active) | — | — | Malignant Neoplasm,Glioblastoma,Adult Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843253Phase 2 · recruiting Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831526early Phase 1 · recruiting Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605364Phase 2/Phase 3 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03688178Phase 2 · active not recruiting DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006273Phase 1 · recruiting A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors · 781 trials list this drug (199 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07599371Phase 1/Phase 2 · recruiting A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · 781 trials list this drug (199 active) | — | — | Solid Neoplasm,Hepatoblastoma,Malignant Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04984733Phase 2 · completed Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer · 781 trials list this drug (199 active) | — | — | Malignant Esophageal Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04477200Phase 1 · active not recruiting Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Astrocytoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614909early Phase 1 · completed Study of Pamiparib in Newly Diagnosed and rGBM · 781 trials list this drug (199 active) | — | — | Glioblastoma,Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02308527Phase 2 · completed Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554707early Phase 1 · withdrawn SGT-53 in Children With Recurrent or Progressive CNS Malignancies · 781 trials list this drug (199 active) | — | — | Childhood Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105374Phase 2/Phase 3 · withdrawn Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Oligodendroglioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07569042Phase 1/Phase 2 · recruiting A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05629702Phase 2 · recruiting ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids · 781 trials list this drug (199 active) | — | — | Glioblastoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03491683Phase 1/Phase 2 · active not recruiting INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200443Phase 2 · active not recruiting Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma · 781 trials list this drug (199 active) | — | — | Soft Tissue Sarcoma,Leiomyosarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562971Phase 1/Phase 2 · not yet recruiting Focused Ultrasound Blood-Brain Barrier Opening in Pontine Diffuse Midline Glioma to Enhance Temozolomide Therapy: Pilot Feasibility Study (FIDES) · 781 trials list this drug (199 active) | — | — | Diffuse Midline Glioma, H3 K27-Altered | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06012695Phase 1/Phase 2 · recruiting NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Malignant Neoplasm,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625047Phase 4 · completed Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioma,Astrocytoma, IDH-Mutant+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297212Phase 2 · recruiting A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396860Phase 2/Phase 3 · completed Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma · 781 trials list this drug (199 active) | — | — | Gliosarcoma,MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864109Phase 2 · active not recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02287428Phase 1 · active not recruiting Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04817254Phase 2 · completed Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Malignant Glioma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093353Phase 1 · completed N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440786Phase 2 · active not recruiting CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06419946Phase 3 · recruiting Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype,MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919382Phase 2 · recruiting Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer · 781 trials list this drug (199 active) | — | — | Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05661643Phase 2 · recruiting The Efficacy and Safety of Temozolomide in SDH-deficient GIST · 781 trials list this drug (199 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574856Phase 2 · active not recruiting Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384821Phase 1/Phase 2 · recruiting Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) · 781 trials list this drug (199 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476794Phase 2 · recruiting Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04890093Phase 1/Phase 2 · suspended Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749187Phase 1 · active not recruiting BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas · 781 trials list this drug (199 active) | — | — | Glioblastoma,Low Grade Glioma,Malignant Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257618NA · completed Quality of Life and Neurocognitive Functioning · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504381Phase 1/Phase 2 · recruiting DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma · 781 trials list this drug (199 active) | — | — | MGMT-Methylated Glioblastoma,MGMT-Unmethylated Glioblastoma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07457307Phase 1 · not yet recruiting Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac · 781 trials list this drug (199 active) | — | — | High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03519412Phase 2 · completed Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status · 781 trials list this drug (199 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238819Phase 1/Phase 2 · completed A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma · 781 trials list this drug (199 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06346067Phase 3 · active not recruiting A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) · 781 trials list this drug (199 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942264Phase 1/Phase 2 · terminated Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Astrocytic Tumor,Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475235Phase 1 · recruiting Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL · 781 trials list this drug (199 active) | — | — | Lymphoma,Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709495Phase 1/Phase 2 · recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas · 781 trials list this drug (199 active) | — | — | Sarcoma,Ewing Sarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794349Phase 2 · active not recruiting Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03830918Phase 1/Phase 2 · active not recruiting Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy · 781 trials list this drug (199 active) | — | — | Malignant Solid Neoplasm,Malignant Lung Neoplasm,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04478279Phase 1/Phase 2 · active not recruiting A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors · 781 trials list this drug (199 active) | — | — | Malignant Breast Neoplasm,Melanoma,Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03405792Phase 2 · active not recruiting Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391215Phase 1/Phase 2 · recruiting 5G-PEARL: Paxalisib in Malignant Brain Tumours · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208657Phase 1/Phase 2 · recruiting Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer · 781 trials list this drug (199 active) | — | — | Malignant Neoplasm,Childhood Malignant Neoplasm,Childhood Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752813Phase 2 · active not recruiting A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365280Phase 2 · not yet recruiting Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216329Phase 1 · active not recruiting Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06630260Phase 1/Phase 2 · recruiting 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours · 781 trials list this drug (199 active) | — | — | Glioblastoma,Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06105619Phase 2/Phase 3 · active not recruiting A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347210Phase 2 · not yet recruiting Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04689347Phase 1/Phase 2 · recruiting 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. · 781 trials list this drug (199 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07334301Phase 1/Phase 2 · recruiting A Multi-Arm, Platform Trial For Relapsed Neuroblastoma · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05083754Phase 1 · recruiting Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05106296Phase 1 · recruiting Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer · 781 trials list this drug (199 active) | — | — | Glioblastoma,Medulloblastoma,Ependymoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095375Phase 1 · completed Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype,MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049669Phase 2 · active not recruiting Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG · 781 trials list this drug (199 active) | — | — | Glioblastoma,Medulloblastoma,Diffuse Intrinsic Pontine Glioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04959500Phase 2 · active not recruiting Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04474353Phase 1 · completed Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116411Phase 2 · active not recruiting A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858168Phase 1 · completed Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma · 781 trials list this drug (199 active) | — | — | Ewing Sarcoma,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040360Phase 2 · recruiting Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors · 781 trials list this drug (199 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05128734Phase 2 · not yet recruiting Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC) · 781 trials list this drug (199 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344355Phase 2 · active not recruiting A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212742Phase 1/Phase 2 · active not recruiting Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03224104Phase 1 · completed Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. · 781 trials list this drug (199 active) | — | — | Anaplastic Astrocytoma,Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03687957Phase 1/Phase 2 · active not recruiting rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide · 781 trials list this drug (199 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945148Phase 2 · recruiting Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide · 781 trials list this drug (199 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · 781 trials list this drug (199 active) | — | — | Acute Lymphoblastic Leukemia,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04250922Phase 2/Phase 3 · active not recruiting LAM561 With RT and TMZ for Adults With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746080Phase 2 · completed Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Malignant Glioma,Glioblastoma with Primitive Neuronal Component+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03672773Phase 2 · active not recruiting Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer · 781 trials list this drug (199 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04385277Phase 2 · active not recruiting Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) · 781 trials list this drug (199 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617923Phase 2 · recruiting Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer · 781 trials list this drug (199 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04373785Phase 1/Phase 2 · not yet recruiting NG101m Adjuvant Therapy in Glioblastoma Patients · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01991977Phase 2 · completed 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy · 781 trials list this drug (199 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685605Phase 3 · active not recruiting Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme · 781 trials list this drug (199 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429502Phase 1 · terminated Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors · 781 trials list this drug (199 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03426891Phase 1 · completed Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma · 781 trials list this drug (199 active) | — | — | Glioblastoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634707early Phase 1 · active not recruiting Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) · 781 trials list this drug (199 active) | — | — | Brain Neoplasm,Primary Brain Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00978458Phase 3 · active not recruiting Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma · 781 trials list this drug (199 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |